Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014, Article ID 261365, 10 pages
http://dx.doi.org/10.1155/2014/261365
Research Article

Expression and Clinical Significance of YAP, TAZ, and AREG in Hepatocellular Carcinoma

1Department of Medical Oncology, The First Affiliated Hospital of Xi’an Jiaotong University Medical College, Xi’an, Shaanxi 710061, China
2Center of Maternal and Child Health, The First Affiliated Hospital of Xi’an Jiaotong University Medical College, Xi’an, Shaanxi 710061, China

Received 31 January 2014; Accepted 2 April 2014; Published 22 April 2014

Academic Editor: W. Martin Kast

Copyright © 2014 Su-xia Han et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. M. Liu, R. T. P. Poon, and J. M. Luk, “MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties,” Biochemical and Biophysical Research Communications, vol. 394, no. 3, pp. 623–627, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Dupont, L. Morsut, M. Aragona et al., “Role of YAP/TAZ in mechanotransduction,” Nature, vol. 474, no. 7350, pp. 179–183, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. K.-P. Lee, J.-H. Lee, T.-S. Kim et al., “The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 18, pp. 8248–8253, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. W. C. Siew, J. L. Chun, K. Guo et al., “A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells,” Cancer Research, vol. 68, no. 8, pp. 2592–2598, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Bai, C. Zhang, N. Liang et al., “Yes-Associated Protein (YAP) increases chemosensitivity of hepatocellular carcinoma cells by modulation of p53,” Cancer Biology & Therapy, vol. 14, no. 6, pp. 511–520, 2013. View at Publisher · View at Google Scholar
  6. L. Jie, W. Fan, Z. Y. Dai Weiqi et al., “The hippo-yes association protein pathway in liver cancer,” Gastroenterology Research and Practice, vol. 2013, Article ID 187070, 7 pages, 2013. View at Publisher · View at Google Scholar
  7. L. Zender, M. S. Spector, W. Xue et al., “Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach,” Cell, vol. 125, no. 7, pp. 1253–1267, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Weissferdt, H. Lin, D. Woods et al., “HER family receptor and ligand status in thymic carcinoma,” Lung Cancer, vol. 77, pp. 515–521, 2012. View at Google Scholar
  9. J. Zhang, J.-Y. Ji, M. Yu et al., “YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway,” Nature Cell Biology, vol. 11, no. 12, pp. 1444–1450, 2009. View at Google Scholar · View at Scopus
  10. N. Yang, C. D. Morrison, P. Liu et al., “TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin,” Cell Cycle, vol. 11, pp. 2922–2930, 2012. View at Google Scholar
  11. W. Li, L. Wang, H. Katoh, R. Liu, P. Zheng, and Y. Liu, “Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers,” Cancer Research, vol. 71, no. 6, pp. 2162–2171, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Zhang, J. Zhang, X. You et al., “Hepatitis B virus X protein modulates oncogene yes-associated protein by CREB to promote growth of hepatoma cells,” Hepatology, vol. 56, pp. 2051–2059, 2012. View at Google Scholar
  13. M. Overholtzer, J. Zhang, G. A. Smolen et al., “Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 33, pp. 12405–12410, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. D. M. Lam-Himlin, J. A. Daniels, M. F. Gayyed et al., “The hippo pathway in human upper gastrointestinal dysplasia and carcinoma: a novel oncogenic pathway,” International Journal of Gastrointestinal Cancer, vol. 37, no. 4, pp. 103–109, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. A. A. Steinhardt, M. F. Gayyed, A. P. Klein et al., “Expression of Yes-associated protein in common solid tumors,” Human Pathology, vol. 39, no. 11, pp. 1582–1589, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Dong, G. Feldmann, J. Huang et al., “Elucidation of a universal size-control mechanism in drosophila and mammals,” Cell, vol. 130, no. 6, pp. 1120–1133, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Xu, C. Liu, W. Huang et al., “Effect of Mst1 overexpression on the growth of human hepatocellular carcinoma HepG2 cells and the sensitivity to cisplatin in vitro,” Acta Biochimica et Biophysica Sinica, vol. 45, pp. 268–279, 2013. View at Google Scholar
  18. K. P. L. Bhat, K. L. Salazar, V. Balasubramaniyan et al., “The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma,” Genes and Development, vol. 25, no. 24, pp. 2594–2609, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. Zhou, Y. Hao, N. Liu, L. Raptis, M.-S. Tsao, and X. Yang, “TAZ is a novel oncogene in non-small cell lung cancer,” Oncogene, vol. 30, no. 18, pp. 2181–2186, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Berasain, J. Castillo, M. J. Perugorría, J. Prieto, and M. A. Avila, “Amphiregulin: a new growth factor in hepatocarcinogenesis,” Cancer Letters, vol. 254, no. 1, pp. 30–41, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Castillo, E. Erroba, M. J. Perugorría et al., “Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells,” Cancer Research, vol. 66, no. 12, pp. 6129–6138, 2006. View at Publisher · View at Google Scholar · View at Scopus